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Background: This paper assesses the agreement between household-level income data and an
area-based income measure, and whether or not discrepancies create meaningful differences when
applied in regression equations estimating total household prescription drug expenditures.
Methods: Using administrative data files for the population of BC, Canada, we calculate income
deciles from both area-based census data and Canada Revenue Agency validated household-level
data. These deciles are then compared for misclassification. Spearman's correlation, kappa
coefficients and weighted kappa coefficients are all calculated. We then assess the validity of using
the area-based income measure as a proxy for household income in regression equations explaining
socio-economic inequalities in total prescription drug expenditures.
Results: The variability between household-level income and area-based income is large. Only 37%
of households are classified by area-based measures to be within one decile of the classification
based on household-level incomes. Statistical evidence of the disagreement between income
measures also indicates substantial misclassification, with Spearman's correlations, kappa
coefficients and weighted kappa coefficients all indicating little agreement. The regression results
show that the size of the coefficients changes considerably when area-based measures are used
instead of household-level measures, and that use of area-based measures smooths out important
variation across the income distribution.
Conclusion:  These results suggest that, in some contexts, the choice of area-based versus
household-level income can drive conclusions in an important way. Access to reliable household-
level income/socio-economic data such as the tax-validated data used in this study would
unambiguously improve health research and therefore the evidence on which health and social
policy would ideally rest.
Background
Measures of income are often central to health and health
policy research. Among many potential implications,
income can be a non-medical determinant of health [1-3]
an enabling factor for access to care[4], or a consideration
when judging equity of policies and programs[5]. As
important as this variable may be, it is often difficult for
health and health policy researchers to obtain reliable,
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individual-level income information for the populations
they study. In the absence of individual-level income data,
investigators often supplement health research datasets
with group-based measures such as area-based average
income constructed from national census data[6]. Such
measures are used as proxy for individual-level income
data on the assumption that household incomes will be
reasonably homogeneous within small enough residen-
tial areas. If, however, there is significant heterogeneity in
the areas used, then the aggregate measures can result in
ecological fallacy–when an association observed between
variables at an aggregate level does not represent the asso-
ciation that exists at an individual level[7].
Prior studies have investigated misclassification of
income and other socio-economic variables by comparing
individual versus area-level survey responses for small
samples of the population[8,9] and by comparing survey-
based measures for different sized census areas[10,11].
Using a unique dataset that contains validated household
income data for approximately 78% of the population of
British Columbia (BC), we investigate the level of misclas-
sification that can occur when census-defined, area-based
income is used as a proxy for an individual's actual house-
hold-level income. As the question of most interest to
researchers concerns how well aggregate variables perform
when they are entered in health outcomes equations, we
then assess the sensitivity of the analysis of health related
inequities in total prescription drug costs to whether
income is measured as an area-based variable or an house-
hold-level variable.
Methods
Data
Our primary datasets are administrative files for the pro-
vincially administered, universal public medical and hos-
pital health insurance program, Medical Services Plan
(MSP) of BC. This program covers virtually all 4.2 million
residents of BC, excluding only those residents covered by
federal health insurance programs (collectively about 4%
of the population). We restrict our attention to house-
holds for which one or more member resided in BC for at
least 275 days per year from 2001 to 2004, inclusive.
Household income was obtained from the 2004 registra-
tion files for provincially administered, universal public
pharmaceutical insurance program, BC PharmaCare. In
addition to programs for social assistance recipients and
other select populations, BC PharmaCare began offering
income-based public drug coverage to all residents of the
province in May 2003. Terms such as deductibles and co-
insurance are based on household income, with more
generous but still income-based coverage offered to senior
citizens (residents aged 65 and older). For all households
that registered to receive coverage, the BC Ministry of
Health obtains net, pre-tax income information from the
Canada Revenue Agency. Because of differences in cover-
age offered and average needs, 95% of households with
one or more senior member were registered for Fair Phar-
maCare in 2004 whereas only 73% of non-senior house-
holds were registered.
The area-based income variables used in this study are
based on linking MSP registry postal codes to average
household income in the area as recorded in the 2001
Census. Statistics Canada collates average household
income and composition for over 7,000 Census Dissemi-
nation Areas comprised of 400 to 700 persons. For
research purposes, these areas are sorted by income and
aggregated into 1,000 strata. Income strata contain an
average of 1,700 households, with some variation due to
variations in populations by postal code. Both the house-
hold level and area-based income variables are based on
the same income concept, gross income prior to any
deductions.
Total individual expenditures on prescription drugs were
obtained from BC PharmaNet. BC PharmaNet is an
administrative dataset in which every prescription dis-
pensed in the province must be entered by law–it is
designed to support drug dispensing, drug monitoring
and claims processing. These individual expenditures
were aggregated at the household level according to regis-
tration files for the MSP program to create a variable indi-
cating total household spending on prescription drugs.
The research data were extracted for this study from the
British Columbia Linked Health Database and the BC
PharmaNet database with permission of the BC Ministry
of Health and the College of Pharmacists of BC. Ethics
approval was obtained from the Behavioural Research
Ethics Board at the University of British Columbia.
Statistical methods
The household-specific and area-based income measures
were each aggregated into deciles (ordered from lowest to
highest income). We assess the discrepancy between the
two measures using the CRA validated, household-spe-
cific incomes as the standard. We calculated the Spear-
man's rank correlations of the various income measures,
and both the kappa and weighted kappa to measure the
degree of non-random agreement and partial agreement
between the measures.
We proceed to examine whether the choice of income
measure has an impact on how pharmaceutical expendi-
tures are distributed by income status. We begin by exam-
ining the distribution of prescription drug expenditures
by income deciles, where the deciles are defined according
to household-level income then according to neighbour-BMC Health Services Research 2008, 8:79 http://www.biomedcentral.com/1472-6963/8/79
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hood level income. As measurement error is accommo-
dated more easily in regression analysis than in
descriptive analysis, we also include a series of dummy
variables for both versions of the income variable in an
OLS regression in order to determine whether both area-
based income and household income generate meaning-
fully different results when applied in a research context.
We perform regressions of income on total drug expendi-
tures with and without covariates controlling for the pres-
ence of one or more seniors in the household as well as
household size. Through the comparison of coefficients
between household-level income variables and area-level
income variables, one can reach some conclusions about
the appropriateness of substituting an area-based measure
for a missing household-level variable in a regression
equation. By including regressions with and without cov-
ariates, we can determine whether multivariate models
influence the discrepancy between area-based and house-
hold-level variables.
Results
A total of 1.74 million households were registered for
MSP and had valid postal codes for linkage with area-
based income strata. This cohort accounts for 95% of the
total population in the province. Of these households,
1.36 million were registered for the Fair PharmaCare pro-
gram. Cross-tabulations of the household-level and area-
based income measures are shown in Table 1, where NR
indicates the percentage of households in each area-based
decile who were not registered for the Fair PharmaCare
program at the time of data collection. This table confirms
that rates of participation with the income-based program
are lower in higher income neighbourhoods. This concen-
tration of low incomes for the household-level income
variable is because the registration for income-based drug
coverage involves a degree of self-selection bias. To adjust
for this, our tables below present a "best case" scenario
wherein all non-registered households are assigned a
hypothetical household-level income variable that is
identical to their area-level income.
Table 2 shows the level of discrepancy between the house-
hold-level and area-based income measures. The area-
based measures classify 15.6% of senior households and
14.9% of non-senior households as being within the same
income-decile as is determined by tax-reported household
income. Approximately a third of non-senior households
and two fifths of senior households are classified by area-
based measures to be within one decile of the classifica-
tion based on household-level incomes. In the "best-case"
scenario, just over half of non-seniors and approximately
43% of seniors are within one decile of their household-
level income.
Statistical evidence of the disagreement between income
measures can be found in Table 3. The Spearman's corre-
lations between the actual household-level income and
area-based measures are always less than 0.40, suggesting
little agreement. The kappa coefficient of non-random,
complete agreement never exceeds 0.31 indicating very lit-
tle complete agreement between area-based and actual
household-level deciles even under the assumption of
perfect correlation between area-based and household-
level measures for all non-registrants. Again, when exam-
ining the weighted kappa coefficients, incorporating par-
tial agreement, we see that they never exceed 0.5, even in
the best-case scenario.
To examine whether these discrepancies result in any
meaningful differences in an applied research context, we
start by examining the distribution of total prescription
drug expenditures by income deciles stratified by senior
and non-senior households, first using household-level
CRA validated income and then using aggregate neigh-
bourhood level income (Table 4). Table 4 indicates that
total prescription drug expenditures appear more equally
Table 1: Entire BC population, 2003. Agreement between household-level validated income deciles and area-based income deciles
Household-level validated income decile
1 2 3 4 5678 9 1 0N R t o t a l
Area-based income decile 1 20.1 13.0 13.1 10.8 7.7 5.7 5.0 3.6 2.6 1.7 16.6 100
2 10.8 10.5 10.7 10.4 9.4 8.2 7.6 5.9 4.6 2.7 19.2 100
39 . 1 9 . 29.7 9.7 9.5 8.7 8.1 6.8 5.7 3.5 20.0 100
47 . 8 8 . 28 . 99.2 9.2 8.8 8.5 7.7 6.7 4.3 20.8 100
5 6.8 7.6 7.7 8.3 8.6 8.7 8.6 8.5 7.8 5.4 22.1 100
6 5.7 7.0 7.1 7.5 8.2 8.6 8.7 8.8 8.9 6.8 22.8 100
7 4.9 6.5 6.3 6.8 7.7 8.4 8.7 9.3 9.7 8.6 23.2 100
8 4.7 6.0 5.6 6.0 6.8 7.9 8.5 9.6 10.8 11.0 23.2 100
9 4.0 5.4 5.0 5.2 6.0 7.4 8.1 9.6 11.1 14.1 24.1 100
10 4.2 4.8 4.2 4.2 4.9 5.9 6.5 8.3 10.2 20.1 26.6 100
Note: NR indicates individuals who were not registered for Fair PharmaCare at the time of data collection.BMC Health Services Research 2008, 8:79 http://www.biomedcentral.com/1472-6963/8/79
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distributed when we rank households by neighbourhood
income than by household-level income, suggesting that
neighbourhood level income masks variation in the
underlying household-level income variable.
In Table 5 we estimate the effect of household income on
total prescription drug expenditures by using both house-
hold-level income and neighbourhood level income in
separate regressions. The dummy variable for the highest
income decile was not included in the regression; thus,
the coefficients can be interpreted as the difference in total
prescription drug costs between each income decile and
the highest income decile. The regression results also
reflect the pattern noted in Table 4. While the signs never
differ, the household-level variables pick up a substan-
tially larger coefficient than the corresponding neighbour-
hood-level variable. This again suggests that the
neighbourhood-level variables are smoothing the distri-
bution of total prescription drug expenditures across
income deciles. While the coefficients on income deciles
differ substantially between the two models, it is interest-
ing to note that the coefficients on presence of seniors and
household size do not. Both coefficients are in the same
direction and are of the same magnitude indicating that
the difference in income variable does not have a large
effect on other coefficients in the model. The model based
on household-level income also reports a higher adjusted
R[2] statistic than that using the area-based measure, indi-
cating that the goodness of fit is higher in the regression
using household-level variables. We also find that the
inclusion of covariates in the model does not attenuate
the bias between the variables substantially (Table 5).
Discussion
We found a sufficient level of discrepancy between the
area-based and household-level income measures. Using
validated household income as the standard, area-based
measures misclassified the income decile for eighty-five
percent or more of the households in the data. We also
found that these discrepancies did affect the size of coeffi-
cients in regression analyses, suggesting that very different
conclusions can be reached regarding the 'same' issue
depending on which income variable we use. Thus, these
results indicate that, at least in some contexts, the choice
of neighbourhood versus household income can drive
conclusions in an important way. Our results are consist-
ent with a large amount of work indicating substantial dis-
crepancy between area-based and household SES
measures[2,6,8,10].
There are also a couple of important caveats. The first is
that our study did not examine the inclusion of income as
simply one of several control variables, but rather only
looked at the difference between household-level and
Table 2: Percentage of discrepancy by decile between area-based and household-level income measures
Area-based Measure Group None One Two Three Four Five Six Seven Eight Nine
Actual household-level income All 14.9 22.5 18.5 14.5 10.8 7.7 5.3 3.3 1.8 0.7
Non-seniors 14.9 21.8 18.2 14.7 11.2 7.9 5.4 3.4 1.8 0.7
Seniors 15.6 23.9 19.1 14.4 10.4 7.2 4.7 2.7 1.4 0.6
Best-case scenario All 33.4 18.3 14.4 11.4 8.3 5.4 4.1 2.6 1.4 0.7
Non-seniors 37.8 16.0 13.3 10.7 8.2 5.8 3.9 2.5 1.3 0.5
Seniors 20.2 22.7 18.0 13.6 9.8 6.8 4.4 2.6 1.3 0.6
Note: In Best-case scenario, non-registered households are assigned a hypothetical household-level income decile that is identical to their area-
based measure.
Table 3: Spearman's correlation, Kappa and weighted Kappa coefficients for the association between the area-based income measures 
and the household income measure
Area-based measure Group rs Kappa Weighted Kappa
Actual household-level income All 0.322 0.055 0.322
Non-seniors 0.316 0.054 0.315
Seniors 0.382 0.060 0.382
Best-case Scenario (including non-registrants) All 0.469 0.260 0.469
Non-seniors 0.497 0.309 0.496
Seniors 0.420 0.113 0.420
Note: rs = Spearman's correlation coefficient.
In Best-Case Scenario, non-registered households are assigned a hypothetical household-level income decile that is identical to their area-based 
measure.BMC Health Services Research 2008, 8:79 http://www.biomedcentral.com/1472-6963/8/79
Page 5 of 7
(page number not for citation purposes)
area-level income when applied as the primary variable of
interest. Thus, results cannot be extended to the use of
income as a control in much larger regression equations.
Second, these results are not meant to suggest that the use
of neighbourhood income is inferior in all contexts. An
author particularly concerned with measuring permanent
income free of yearly fluctuations may find that neigh-
bourhood income provides a better measure. When meas-
uring access to health care, it might also be true that low-
income families living in high-income neighbourhoods
have better access to care than other similar low-income
families simply because of where they live. Thus, an argu-
ment could be made for including both measures in this
type of work.
While the level of agreement between area-based and
household-level SES measures has frequently been stud-
ied, our work adds to the knowledge base for several rea-
sons. It encompasses a larger number of Canadians, a
sample of 78% of all households in British Columbia, of
Table 4: Total drug costs by income decile
Entire BC population Non-senior population Senior population
Mean total drug 
costs
Percent of total 
drug costs
Mean total drug 
costs
Percent of total 
drug costs
Mean total drug 
costs
Percent of total 
drug costs
Deciles measured by CRA validated income
1 ($900–3,750) 743.27 10.39 826.46 15.24 894.61 6.99
2 ($3750–12,000) 615.16 8.60 456.26 8.41 942.67 7.37
3 ($12,000–
16,000)
605.19 8.46 332.54 6.13 1059.92 8.28
4 ($16,000–
20,000)
681.31 9.53 334.55 6.17 1178.95 9.21
5 ($20,000–
29,375)
534.48 7.47 358.74 6.61 1280.50 10.01
6 ($29,375–
39,584)
653.91 9.14 411.01 7.58 1352.22 10.57
7 ($29,584–
51,250)
705.15 9.86 503.90 9.29 1420.86 11.11
8 ($51,250–
67,917)
821.07 11.48 654.20 12.06 1499.01 11.72
9 ($67,917–
91,667)
881.27 12.32 741.34 13.67 1565.45 12.24
10 ($91,667–
475,000)
912.01 12.75 804.41 14.83 1599.72 12.50
100 100 100
Deciles measured by neighbourhood income
1 ($4,200–20,100) 726.63 10.16 615.32 11.35 1109.80 8.67
2 ($20,100–
23,800)
653.33 9.13 499.71 9.21 1189.72 9.30
3 ($23,800–
26,500)
697.09 9.75 511.38 9.43 1245.68 9.74
4 ($26,500–29,00) 700.24 9.79 510.90 9.42 1273.95 9.96
5 ($29,00–31,300) 707.28 9.89 523.97 9.66 1271.18 9.94
6 $31,300–33,900) 711.68 9.95 531.67 9.80 1309.01 10.23
7 ($33,900–
36,900)
720.97 10.08 540.98 9.97 1323.70 10.35
8 ($36,900–
41,300)
722.07 10.09 545.90 10.07 1343.11 10.50
9 ($41,300–
48,900)
728.69 10.19 554.05 10.22 1349.44 10.55
10 ($48,900–
310,900)
784.83 10.97 589.86 10.87 1378.30 10.77
100 100 100
Note: All numbers are based on the best-case scenario in which all non-registered households are assigned a hypothetical individual-level income 
decile that is identical to their area-based measure.BMC Health Services Research 2008, 8:79 http://www.biomedcentral.com/1472-6963/8/79
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which 95% of all senior households are analyzed. Also,
while other studies have tended to compare area-based
measures to household-level survey data[6,8,9] or have
compared two or more different sized area-based meas-
ures[10,11] we have used highly reliable household-level
income data validated with the Canada Revenue Agency.
Therefore, we have been able to avoid all self-reporting
bias, we have a great deal of confidence in our household-
level income variable, and we have been able to analyze
almost an entire population of a Canadian province.
Conclusion
While many authors have argued that household-level
income should be used whenever possible, census-based
aggregate measures will continue to be necessary for
health research until household-level data become more
readily available. Two suggestions can be made based on
these research results. The first is that researchers should
be cautious when interpreting the results of studies using
aggregate measures as proxies for individual and house-
hold income. Area-based measures are approximations
that are best suited to investigating major differences in
incomes (e.g., differences of two or more quintiles) or to
studying context in which someone lives rather than their
specific income. The second suggestion is perhaps obvi-
ous to researchers but important for governments and sta-
tistical agencies to fully understand: access to reliable
individual-level income/socio-economic data, as well as
the neighbourhood level income data that is currently
available, would unambiguously improve health research
and therefore the evidence on which health and social
policy would ideally rest.
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